In vitro studies of some chlorpromazine metabolites as potential N-methyltransferase inhibitors
Sangiah, S.; Domino, E.F.
Research Communications in Chemical Pathology and Pharmacology 16(2): 389-392
1977
ISSN/ISBN: 0034-5164 PMID: 847293 Document Number: 116063
A series of chlorpromazine metabolites were tested as inhibitors of rabbit lung N-methyltransferase activity in vitro. The hydroxylated metabolites were found to be more effective with the 7,8 dioxy derivatives the most potent. Various chelating agents had no effect, suggesting that the inhibitory effects of the hydroxy metabolites were not due to divalent cation chelation.
Document emailed within 1 workday
Related Documents
Ziemsen, B.; Agarwal, D.P.; Hoo, J.J.; Goedde, H.W. 1983: The effect of lithium, imipramine and chlorpromazine on the membrane bound enzyme phosphatidylethanolamine methyltransferase Arzneimittel-Forschung 33(11): 1523-1524Katori, M. 1982: Recent progress in the studies of prostaglandins--new arachidonic acid metabolites and inhibitors Nihon Rinsho. Japanese Journal of Clinical Medicine 40(1): 232-246
Gülerman, N.; Rollas, S.; Ulgen, M. 1998: Synthesis and in vitro microsomal metabolism of 4-ethyl-5-(4-fluorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione and its potential metabolites Bollettino Chimico Farmaceutico 137(5): 140-143
Schmoldt, A.; Blömer, J. 1985: In vitro studies on glucuronidation of digitoxin and its metabolites Beitrage Zur Gerichtlichen Medizin 43: 149-153
Prokof'eva, M.M.; Orlova, N.N.; Gornostaeva, A.S.; Shul'gin, A.A.; Nikitenko, N.A.; Senchenko, V.N.; Lebedev, T.D.; Spirin, P.V.; Riechen, K.; Fehse, B.; Stocking, C.; Prasolov, V.S. 2014: Universal modular system for in vitro screening of potential inhibitors of HIV-1 replication Molekuliarnaia Biologiia 48(2): 344-348
Krynetski, E.Y.; Krynetskaia, N.F.; Yanishevski, Y.; Evans, W.E. 1995: Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase Molecular Pharmacology 47(6): 1141-1147
Wiggins, J.F.; Sved, A.F.; Fernstrom, J.D. 1980: Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies Journal of Pharmacology and Experimental Therapeutics 212(2): 304-308
Raig, P.; Beschorner, J.; Ammon, R. 1976: Comparative studies in vivo and in vitro on the formation of phenolic biphenyl metabolites in various animal species[ Arzneimittel-Forschung 26(12): 2178-2182
Rapin, J.R.; Caillard, R.C.; Cohen, Y.; Valette, G. 1971: Action of catechol O methyltransferase inhibitors on the distribution of norepinephrine-H 3 in rats Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(1): 60-64
Biagi, G.; Dell'Omodarme, G.; Ferretti, M.; Giorgi, I.; Livi, O.; Scartoni, V.; Tiscione, E. 1990: Studies on 1,2,3-triazole derivatives as in vitro inhibitors of prostaglandin synthesis Farmaco 45(11): 1181-1192
Yamazaki, H.; Shimada, T. 1998: Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(11): 1053-1057
Grunewald, G.L.; Ye, Q.; Sall, D.J.; Criscione, K.R.; Wise, B. 1989: Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase Molecular Pharmacology 35(1): 93-97
Lodde, V.; Modina, S.C.; Franciosi, F.; Zuccari, E.; Tessaro, I.; Luciano, A.M. 2010: Localization of DNA methyltransferase-1 during oocyte differentiation, in vitro maturation and early embryonic development in cow European Journal of Histochemistry 53(4): 199-207
Vetulani, J. 1973: The action of neuroleptics in rats with altered catecholamine metabolism. I. the influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine Polish Journal of Pharmacology and Pharmacy 25(1): 41-52
Ammon, H.P.; Orci, L.; Steinke, J. 1973: Effect of chlorpromazine (CPZ) on insulin release in vivo and in vitro in the rat Journal of Pharmacology and Experimental Therapeutics 187(2): 423-429
Pendleton, R.G.; Gessner, G.; Weiner, G.; Jenkins, B.; Sawyer, J.; Bondinell, W.; Intoccia, A. 1979: Studies on SK&F 29661, an organ-specific inhibitor of phenylethanolamine N-methyltransferase Journal of Pharmacology and Experimental Therapeutics 208(1): 24-30
Szalay, K.S. 1973: In vitro aldolsterone production: effect of ethacrynic acid, chlorpromazine and veratrine Acta Physiologica Academiae Scientiarum Hungaricae 43(3): 275-279
Forrest, I.S.; Green, D.E.; Serra, M.T.; Soave, O.A. 1975: Chlorpromazine excretion in chronically dosed primates. I. Occurrence of a previously unreported class of chlorpromazine conjugates Psychopharmacology Communications 1(1): 51-59
Chaudhary, A.K.; Hubbard, J.W.; McKay, G.; Midha, K.K. 1988: Identification of a quaternary ammonium-linked glucuronide of chlorpromazine in the urine of a schizophrenic patient treated with chlorpromazine Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(3): 506-508
Woodson, L.C.; Dunnette, J.H.; Weinshilboum, R.M. 1982: Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies Journal of Pharmacology and Experimental Therapeutics 222(1): 174-181